Tumour lysis syndrome

ICD-11 code : 5D01;

Preferred Label : Tumour lysis syndrome;

ICD-11 definition : This is a group of metabolic complications that can occur after treatment of cancer, usually lymphomas and leukaemias, and sometimes even without treatment. These complications are caused by the breakdown products of dying cancer cells and include hyperkalemia, hyperphosphatemia, hyperuricemia and hyperuricosuria, hypocalcemia, and consequent acute uric acid nephropathy and acute renal failure.;

ICD-11 inclusion : Tumour lysis spontaneous; Tumour lysis following antineoplastic drug therapy;

Details

Origin ID

1913126571;

UMLS CUI

C0041364;

Currated CISMeF NLP mapping
- TUMOUR LYSIS SYNDROME [WHO-ART Preferred Term]
- Tumor Lysis Syndrome [NCIt concept]
- Tumor lysis syndrome [MedDRA LLT]
- Tumor lysis syndrome [PASCAL descriptor]
- Tumor lysis syndrome [ICD-10 Sub-category]
- Tumor lysis syndrome (disorder) [SNOMED CT concept]
- Tumour lysis syndrome [MedDRA Preferred Term]
- tumor lysis syndrome [MeSH Descriptor]
- tumor lysis syndrome [MeSH concept]
- tumor lysis syndrome [Disease (Nov.)]
ICD-10 Mapping
- Tumor lysis syndrome [ICD-10 Sub-category]
Semantic type(s)
- Disease or Syndrome [UMLS semantic type]
UMLS correspondences (same concept)
- TUMOUR LYSIS SYNDROME [WHO-ART Preferred Term]
- Tumor Lysis Syndrome [NCIt concept]
- Tumor lysis syndrome [ICD-9 code]
- Tumor lysis syndrome [ICD-10 Sub-category]
- Tumor lysis syndrome [MedDRA LLT]
- Tumor lysis syndrome [PASCAL descriptor]
- Tumor lysis syndrome (disorder) [SNOMED CT concept]
- Tumour lysis syndrome [MedDRA Preferred Term]
- tumor lysis syndrome [MeSH Descriptor]
- tumor lysis syndrome [MeSH concept]
- tumor lysis syndrome [Disease (Nov.)]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients